Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

Abstract Background Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically...

Full description

Bibliographic Details
Main Authors: Sigismond Lasocki, Pierre Asfar, Samir Jaber, Martine Ferrandiere, Thomas Kerforne, Karim Asehnoune, Philippe Montravers, Philippe Seguin, Katell Peoc’h, Soizic Gergaud, Nicolas Nagot, Thibaud Lefebvre, Sylvain Lehmann, the Hepcidane study group
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Critical Care
Subjects:
Critically ill
Anemia
Iron deficiency
Iron (treatment)
Hepcidin
Mortality
Online Access:https://doi.org/10.1186/s13054-020-03430-3

Internet

https://doi.org/10.1186/s13054-020-03430-3

Similar Items